XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segment Reporting | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Segment Reporting | SEGMENT REPORTING Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include diagnostic and information technology-based products and services for the veterinary sector, which we refer to as the Companion Animal Group (“CAG”), water quality products (“Water”), and diagnostic products and services for livestock and poultry health and to ensure the quality and safety of milk and improve producer efficiency, which we refer to as Livestock, Poultry and Dairy (“LPD”). Although our LPD segment does not meet the quantitative thresholds to be reported as a separate segment, we believe it is important to disaggregate these revenues as a major product and service category within our Other reportable segment given its distinct markets, and therefore we have elected to report LPD as a reportable segment. Our Other operating segment combines and presents products and services for the human medical diagnostics sector with our out-licensing arrangements. Assets are not allocated to segments for internal reporting purposes. The following is a summary of segment performance:
(in thousands) |  | For the Three Months Ended September 30,
|  | CAG |  | Water |  | LPD |  | Other |  | Consolidated Total
2022 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 764,990 |  |  | $ | 40,840 |  |  | $ | 28,452 |  |  | $ | 7,379 |  |  | $ | 841,661 |
Income from operations |  | $ | 221,454 |  |  | $ | 19,924 |  |  | $ | 4,480 |  |  | $ | (1,030) |  |  | $ | 244,828 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (10,645) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 234,183 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 53,245 |
Net income |  |  |  |  |  |  |  |  |  | 180,938 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | — |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 180,938 |
2021 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 732,495 |  |  | $ | 38,143 |  |  | $ | 29,126 |  |  | $ | 10,657 |  |  | $ | 810,421 |
Income from operations |  | $ | 201,947 |  |  | $ | 17,599 |  |  | $ | 3,600 |  |  | $ | 2,816 |  |  | $ | 225,962 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (7,012) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 218,950 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 43,772 |
Net income |  |  |  |  |  |  |  |  |  | 175,178 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | (57) |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 175,235 |
(in thousands) |  | For the Nine Months Ended September 30,
|  | CAG |  | Water |  | LPD |  | Other |  | Consolidated Total
2022 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 2,310,261 |  |  | $ | 116,406 |  |  | $ | 89,211 |  |  | $ | 22,878 |  |  | $ | 2,538,756 |
Income from operations |  | $ | 601,105 |  |  | $ | 54,498 |  |  | $ | 14,447 |  |  | $ | 2,188 |  |  | $ | 672,238 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (25,481) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 646,757 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 139,875 |
Net income |  |  |  |  |  |  |  |  |  | 506,882 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | — |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 506,882 |
2021 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 2,170,857 |  |  | $ | 109,374 |  |  | $ | 101,920 |  |  | $ | 32,119 |  |  | $ | 2,414,270 |
Income from operations |  | $ | 649,892 |  |  | $ | 49,599 |  |  | $ | 24,276 |  |  | $ | 9,070 |  |  | $ | 732,837 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (22,066) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 710,771 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 128,698 |
Net income |  |  |  |  |  |  |  |  |  | 582,073 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | (1) |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 582,074 |
Refer to “Note 3. Revenue Recognition” for a summary of disaggregated revenue by reportable segment and by major product and service category for the three and nine months ended September 30, 2022 and 2021.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration